| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | BMS-509744 | GDSC1000 | pan-cancer | AAC | 0.14 | 0.02 |
| mRNA | Bortezomib | FIMM | pan-cancer | AAC | 0.35 | 0.02 |
| mRNA | CI-1040 | GDSC1000 | pan-cancer | AAC | -0.082 | 0.02 |
| mRNA | lovastatin | CTRPv2 | pan-cancer | AAC | 0.088 | 0.02 |
| mRNA | NG-25 | GDSC1000 | pan-cancer | AAC | -0.073 | 0.02 |
| mRNA | temsirolimus | GDSC1000 | pan-cancer | AAC | 0.084 | 0.02 |
| mRNA | apicidin | CTRPv2 | pan-cancer | AAC | -0.072 | 0.02 |
| mRNA | ATRA | GDSC1000 | pan-cancer | AAC | -0.082 | 0.02 |
| mRNA | BRD-K34485477 | CTRPv2 | pan-cancer | AAC | 0.18 | 0.02 |
| mRNA | Vorinostat | GDSC1000 | pan-cancer | AAC | -0.074 | 0.02 |